Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$22.91

+4.80%

Mkt Cap $2.97B

EPS — Estimate vs Actual

Mkt Cap

$2.97B

P/E

Fwd P/E

P/S

131.59

Rev TTM

EPS TTM

-$1.81